We are live on ! Find out more
RGLS

Regulus Therapeutics
RGLS

Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

88 hedge funds and large institutions have $555M invested in Regulus Therapeutics in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

484% more call options, than puts

Call options by funds: $27.4M | Put options by funds: $4.7M

90% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 20

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

40% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 15

19% more capital invested

Capital invested by funds: $468M → $555M (+$87.4M)

6% more funds holding

Funds holding: 83 → 88 (+5)

Holders
88
Holders Change
+5
Holders Change %
+6.02%
% of All Funds
2.35%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
38
Reduced
20
Closed
15
Calls
$27.4M
Puts
$4.7M
Net Calls
+$22.7M
Net Calls Change
+$22.1M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$29.5M
2
OIM
Oracle Investment Management
Connecticut
+$23.3M
3
FCMI
Foresite Capital Management II
California
+$7.78M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.2M
5
Goldman Sachs
Goldman Sachs
New York
+$4.58M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$20.9M
2
O
OrbiMed
New York
-$6.42M
3
CAM
Cormorant Asset Management
Massachusetts
-$3.69M
4
CS
Candriam SCA
Luxembourg
-$2.93M
5
SM
Sabby Management
Florida
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
76
BlackRock Advisors
Delaware
$174K +$26.1K +12 +16%
AIG
77
American International Group
New York
$147K – – –
UBS Group
78
UBS Group
Switzerland
$112K +$102K +47 +588%
LTFS
79
Ladenburg Thalmann Financial Services
Florida
$34K – – –
Barclays
80
Barclays
United Kingdom
$16K -$36.9K -17 -65%
Simplex Trading
81
Simplex Trading
Illinois
$10K +$10.9K +5 New
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
$6.25K +$6.52K +3 New
BlackRock
83
BlackRock
New York
$6K – – –
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$3K +$4.35K +2 New
Bank of America
85
Bank of America
North Carolina
$2K -$69.5K -32 -97%
MAA
86
Managed Account Advisors
New Jersey
$2K -$2.17K -1 -50%
Bank of Montreal
87
Bank of Montreal
Ontario, Canada
$1K – – –
Manulife (Manufacturers Life Insurance)
88
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$183 +$19.6K +9 +11%
O
89
OrbiMed
New York
– -$6.42M -3,333 Closed
CC
90
Callan Capital
California
– -$1.28M -667 Closed
UOC
91
UBS O'Connor
Illinois
– -$1.28M -667 Closed
RFC
92
Russell Frank Company
Washington
– -$1.01M -524 Closed
EI
93
EAM Investors
California
– -$961K -499 Closed
ACPU
94
Arrowgrass Capital Partners (US)
Delaware
– -$802K -417 Closed
DC
95
Deere & Company
Illinois
– -$462K -240 Closed
Two Sigma Investments
96
Two Sigma Investments
New York
– -$351K -183 Closed
Millennium Management
97
Millennium Management
New York
– -$269K -140 Closed
VAM
98
Verity Asset Management
North Carolina
– -$193K -101 Closed
SG Americas Securities
99
SG Americas Securities
New York
– -$157K -82 Closed
GGHC
100
Gilder Gagnon Howe & Co
New York
– -$120K -62 Closed
1 2 3
4
5

RGLS Hedge Fund Activity: Q1 2015 in Review

88 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Regulus Therapeutics (RGLS) for Q1 2015, worth a combined $555M — up 19% from $468M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RGLS positions and 15 closed out — a net gain of 6 holders — while 38 added to existing stakes and 20 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $29.5M. The largest seller was RA Capital Management, cutting an estimated $20.9M.

  • 88 institutional investors held Regulus Therapeutics (RGLS) as of Q1 2015, up from 83 in Q4 2014.
  • Funds reported $555M of Regulus Therapeutics stock for Q1 2015, up 19% quarter-over-quarter.
  • 21 funds opened new Regulus Therapeutics positions in Q1 2015 and 15 closed out, a net change of +6 holders.
  • The largest Regulus Therapeutics buyer in Q1 2015 was Wellington Management Group, an estimated $29.5M added.
  • The largest Regulus Therapeutics seller in Q1 2015 was RA Capital Management, an estimated $20.9M sold.

Based on aggregated 13F filings for Q1 2015.